NURS FPX 9030 Assessment 3 Manuscript: Draft

NURS FPX 9030 Assessment 3 Manuscript: Draft Student Name School of Nursing and Health Sciences, Capella University NURS-FPX9030 Doctor of Nursing Practice 4 Professor Name Submission Date Introduction The identified critical practice gap is the poor glycemic control of adult patients with type 2 diabetes mellitus, as the lack of a well-established protocolized pathway of the follow-up procedure in outpatient primary care settings leads to the lack of opportunities for receiving education and inconsistent medication reviews, as well as the introduction of complications that could have been prevented. In the site of the project, 42 out of 100 of the adult patients reported having a hemoglobin A1c level above 9, and only 36 out of 100 reported a level below 7, which are considerably higher than any nationally recommended values, which is about 22 percent of the U.S. adult patients with diabetes having poor glucose control (APRN, personal communication, November 2025). In areas of primary care, even with the clinical practice guidelines that have been developed by the American Diabetes Association, there still exist gaps in the implementation of nurse-led follow-up, staff competency, and organization of patient education. The PICOT question that will guide the project is as follows: In nursing staff and adult patients with diabetes (P), the intervention of the implementation of the ADA diabetes follow-up protocol (I) as opposed to current practices (C), how does the glycemic control impact (O) over a 8 weeks period (T)? A systematic ADA-based follow-up strategy, involving personnel development of competencies and patient self-management training, will yield clinically significant changes in glycemic results and improve evidence-based chronic disease management in outpatient primary care. Practice Problem Primary treatment of chronic diseases in an outpatient-based management necessitates a scientific, evidence-based method that helps to address the long-standing gap between the glycemic control of adults with type 2 diabetes and the laid-down health system standards. The data gathered on a site level with regard to the primary care clinic (outpatient) revealed that 42% of adult patients reported a hemoglobin A1c of more than 9 percent, and only 36 percent reported a hemoglobin A1c of less than 7 percent (APRN, personal communications, November 2025). At the national level, approximately a quarter of all adults with diabetes has a poor glycemic control, and approximately half of the world adult population with diabetes never reached a 25 centimetre (HbA1c) less than 7, which proves that the data on the site performance is high enough, by far, to meet the national health system indicators (Adjei et al., 2025; Dinavari et al., 2023). A quarter of adults in the U.S and Europe still have a hemoglobin A1C of more than 9 per cent, indicating that the metabolic control of these individuals was extremely poor (Gomes et al., 2022). Behavioral and demographic factors have been blamed as the main causes of poor glycemic control practices in adults who are already in an outpatient diabetes clinic, indicating the need to identify the people who are at high risk of having poor glycemic control early and apply well-structured clinical intervention to regain control (Karmakar et al., 2025). Quantitative information obtained on the site assists in developing a quantifiable foundation of a quality improvement intervention that is aimed at the practicum site. A total assessment of the current workflow, process flows, staffing patterns, and measures of care coordination within the clinical setting is necessary to effectively determine the causal factors that underlie poor glycemic control. The review of charts and documentation of EHR on site showed that inconsistent scheduling, lack of increased follow-up, and inconsistency in delivering education were part of essential process failures that led to sub-optimal glycemic outcomes (APRN, personal communication, November 2025). The absence of a standardized and protocolized follow-up pathway contributed to ad hoc scheduling, inconsistent use of EHR reminders, the lack of multidisciplinary coordination, which caused delay in timely emergency changes in medications, and the individual coloring of patients at the highest risk of complications (APRN, personal communication, November 2025). The rate of follow-up visits and EHR documentation audits further revealed systemic processes malfunctions in visit scheduling and initiation of proactive communication with patients (APRN, personal communication, November 2025). Earlier attempts to enhance the outcomes of diabetes with the help of general education sessions and regular check-ins with a telehealth provider were sporadic in terms of timing and did not include a systematic means of evaluation. Structural quality of teaching was not consistent, and the content of the teaching was not fully comprehended by patients (Dailah, 2024). In this way, a generic needs assessment confirmed the absence of a protocol-based follow-up pathway that serves as the main factor that can be affected by a practice gap. Chronic disease management initiatives that are part of quality improvement initiatives will demand a lot of consideration of the extent to which all the affected stakeholders are impacted to justify ending timely and systemic intervention. The main stakeholders that can be affected by the current glycemic disparities are nursing professionals, diabetes patients, and organizational managers; uncontrolled diabetes has been identified to cause the rise of hospitalization rates, frequency of healthcare usage, and long-term costs of complications of heart disease, neuropathy, and avoidable hospital admissions. Structured interventions and follow-up programs run by nurses have demonstrated significant ability to decrease levels of HbA1c and improve results on adherence, demonstrating that the timely adoption of effective evidence-based interventions was clinically inexcusable and that evidence-based interventions can lead to significant changes in HbA1c levels ranging between 0.4 and 0.9 percentage points (Sun et al., 2025). An endemic disparity in glycemic management at the national level is reported to exist, especially in vulnerable and low-income patients; therefore, the urgent need to intervene with the help of standardized methods at the project location (Centers for Disease Control and Prevention, 2024). To this end, to fill the identified practice gap, it was not only a clinical requirement but also an organizational strategic indicator to fulfill the aims of the proposed primary care mission, which is to be available and